95%Confidence
0Views
FDASource
2026-03-16Date
Summary
FDA recall for Wizcure Pharmaa's ophthalmic strips due to sterility and cGMP issues indicates significant quality control failures at the manufacturer Omni Lens. This poses regulatory and reputational risks for distributor HUB Pharmaceuticals and may impact supply of diagnostic eye care products.
Actionable: Monitor HUB Pharmaceuticals for potential supply disruptions and regulatory scrutiny.
AI Confidence: 95%
Data Points
firmWizcure Pharmaa Private Limited
classificationClass II
statusOngoing
distributionDistributed Nationwide in the USA
productBioGlo Fluorescein Sodium Ophthalmic Strips USP, 100 diagnostic strips, Manufactured by Omni Lens PVT. Ltd., 5 - Samrudhhi, Opp. Sakar-III, Navrangpur
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now